Search

Pulse Biosciences Inc

Fechado

SetorSaúde

53.09 0.76

Visão Geral

Variação de preço das ações

24h

Atual

Mín

52.27

Máximo

53.28

Indicadores-chave

By Trading Economics

Rendimento

-6.1M

-25M

Vendas

33K

434K

EPS

-0.36

Margem de lucro

-5,681.336

Funcionários

116

EBITDA

-5.5M

-24M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+17.57% upside

Dividendos

By Acuity

Próximos Ganhos

5 de nov. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

780M

3.4B

Abertura anterior

52.33

Fecho anterior

53.09

Pulse Biosciences Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de out. de 2026, 20:07 UTC

Pulse Biosciences Inc shares are advancing, continuing an upward trend since Thursday, despite earlier pulling back from a session high.

22 de out. de 2026, 20:07 UTC

Pulse Biosciences Inc shares advanced, reflecting a broader upward trend in the market, which has seen a cumulative return of 2.87% since Wednesday's close.

21 de out. de 2026, 20:07 UTC

Pulse Biosciences Inc is trading modestly higher, aligning with significant overall market gains, and remains above its 20-day moving average.

20 de out. de 2026, 22:11 UTC

Pulse Biosciences Inc shares declined in after-market trading, following a notable drop at Tuesday's close amid weakness in the Health Care Equipment sub-sector.

16 de out. de 2026, 20:07 UTC

Pulse Biosciences Inc shares declined significantly, finishing well below their 20-day moving average after a downward trend that began Thursday.

15 de out. de 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, marking the fifth consecutive session of declines, closing significantly below its 20-day moving average.

14 de out. de 2026, 21:51 UTC

Pulse Biosciences Inc is trading lower in after-market hours, continuing a trend of three consecutive lower closes amid broader market declines following rising inflation.

13 de out. de 2026, 20:01 UTC

Social Media

Oppenheimer raises its price target on Pulse Biosciences Inc to 60 from 35 while maintaining an Outperform rating after a non-deal roadshow.

12 de out. de 2026, 20:06 UTC

Pulse Biosciences Inc shares are declining, continuing a downward trend since Friday.

9 de out. de 2026, 22:20 UTC

Pulse Biosciences Inc shares are declining in after-market trading, hitting their lowest point since Friday's close after a brief opening gain.

7 de out. de 2026, 20:07 UTC

Event

Shares of Pulse Biosciences Inc are declining despite the successful enrollment of 164 patients in its NANOPULSE-AF Study, remaining below its 20-day moving average.

5 de out. de 2026, 20:06 UTC

Pulse Biosciences Inc is advancing, continuing its upward trend since Friday, despite an earlier pullback from a session high. The health care equipment sector shows notable gains.

2 de out. de 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, closing at their lowest point amid broader market weakness and trading below the 20-day moving average.

1 de out. de 2026, 20:07 UTC

Pulse Biosciences Inc shares fell sharply, pulling back from a morning peak and remaining below its 20-day moving average.

30 de set. de 2026, 21:01 UTC

Pulse Biosciences Inc closed lower in after-market trading, marking its fourth consecutive session of decline and remaining significantly below its 20-day moving average.

29 de set. de 2026, 21:21 UTC

Pulse Biosciences Inc has declined in after-market trading, moving lower since Tuesday's close and falling below its 20-day moving average.

28 de set. de 2026, 22:21 UTC

Pulse Biosciences Inc saw a significant increase in after-market trading, reaching a notable peak and remaining well above its 20-day moving average.

25 de set. de 2026, 20:07 UTC

Pulse Biosciences Inc shares fell modestly as the broader market declined, continuing a trend of five consecutive sessions finishing lower.

24 de set. de 2026, 20:07 UTC

Pulse Biosciences Inc. shares fell sharply, continuing a trend of declines over the last four sessions after an earlier gain in the current session.

23 de set. de 2026, 19:25 UTC

Pulse Biosciences Inc shares fell modestly, continuing a downward trend observed over the past three sessions, despite initially rising sharply after the market opened.

22 de set. de 2026, 19:34 UTC

Pulse Biosciences Inc shares fell sharply, declining from Monday's close despite remaining above the 20-day moving average and within the one-month range.

21 de set. de 2026, 20:12 UTC

Pulse Biosciences Inc declined in after-market trading following Monday's close, remaining flat throughout the session but positioned above its 20-day moving average.

18 de set. de 2026, 20:02 UTC

Pulse Biosciences Inc shares are rising sharply, reaching a notable high and trading above its 20-day moving average with unusually high volume.

17 de set. de 2026, 20:07 UTC

Pulse Biosciences Inc is gaining, reflecting positive movement in the health care equipment sector, despite pulling back from an earlier session high.

16 de set. de 2026, 23:36 UTC

Pulse Biosciences Inc is declining in after-market trading, remaining significantly below its 20-day moving average and near the lower end of its one-month range.

15 de set. de 2026, 22:02 UTC

News
Event

Pulse Biosciences has an $85 million equity distribution agreement with Mizuho. Shares are trading lower in after-market hours following the announcement.

14 de set. de 2026, 20:08 UTC

Pulse Biosciences Inc shares are higher today, maintaining a strong position since Friday's close and peaking significantly above the 20-day moving average.

11 de set. de 2026, 20:08 UTC

Pulse Biosciences Inc is declining in Friday's trading session, continuing a downward trend since Thursday. The stock remains above its 20-day moving average.

10 de set. de 2026, 20:01 UTC

Pulse Biosciences Inc shares are higher today amid strong trading volume. The stock remains above its 20-day moving average, reflecting broader market trends.

9 de set. de 2026, 22:01 UTC

Pulse Biosciences shares moved higher in after-market trading, remaining above the 20-day moving average and near the upper end of their one-month range.

Comparação entre Pares

Variação de preço

Pulse Biosciences Inc Previsão

Preço-alvo

By TipRanks

17.57% parte superior

Previsão para 12 meses

Média 62.333 USD  17.57%

Máximo 73 USD

Mínimo 55 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Pulse Biosciences Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

6

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.
help-icon Live chat